These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30595457)

  • 1. Structure of Calcarisporiella thermophila Hsp104 Disaggregase that Antagonizes Diverse Proteotoxic Misfolding Events.
    Michalska K; Zhang K; March ZM; Hatzos-Skintges C; Pintilie G; Bigelow L; Castellano LM; Miles LJ; Jackrel ME; Chuang E; Jedrzejczak R; Shorter J; Chiu W; Joachimiak A
    Structure; 2019 Mar; 27(3):449-463.e7. PubMed ID: 30595457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic genetic variation revealed in diverse Hsp104 homologs.
    March ZM; Sweeney K; Kim H; Yan X; Castellano LM; Jackrel ME; Lin J; Chuang E; Gomes E; Willicott CW; Michalska K; Jedrzejczak RP; Joachimiak A; Caldwell KA; Caldwell GA; Shalem O; Shorter J
    Elife; 2020 Dec; 9():. PubMed ID: 33319748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split conformation of Chaetomium thermophilum Hsp104 disaggregase.
    Inoue Y; Hanazono Y; Noi K; Kawamoto A; Kimatsuka M; Harada R; Takeda K; Kita R; Iwamasa N; Shibata K; Noguchi K; Shigeta Y; Namba K; Ogura T; Miki K; Shinohara K; Yohda M
    Structure; 2021 Jul; 29(7):721-730.e6. PubMed ID: 33651974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity.
    Tariq A; Lin J; Jackrel ME; Hesketh CD; Carman PJ; Mack KL; Weitzman R; Gambogi C; Hernandez Murillo OA; Sweeny EA; Gurpinar E; Yokom AL; Gates SN; Yee K; Sudesh S; Stillman J; Rizo AN; Southworth DR; Shorter J
    Cell Rep; 2019 Aug; 28(8):2080-2095.e6. PubMed ID: 31433984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.
    Jackrel ME; DeSantis ME; Martinez BA; Castellano LM; Stewart RM; Caldwell KA; Caldwell GA; Shorter J
    Cell; 2014 Jan; 156(1-2):170-82. PubMed ID: 24439375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.
    Sweeny EA; Tariq A; Gurpinar E; Go MS; Sochor MA; Kan ZY; Mayne L; Englander SW; Shorter J
    J Biol Chem; 2020 Feb; 295(6):1517-1538. PubMed ID: 31882541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Insights into Hsp104 Potentiation.
    Torrente MP; Chuang E; Noll MM; Jackrel ME; Go MS; Shorter J
    J Biol Chem; 2016 Mar; 291(10):5101-15. PubMed ID: 26747608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning Hsp104 specificity to selectively detoxify α-synuclein.
    Mack KL; Kim H; Barbieri EM; Lin J; Braganza S; Jackrel ME; DeNizio JE; Yan X; Chuang E; Tariq A; Cupo RR; Castellano LM; Caldwell KA; Caldwell GA; Shorter J
    Mol Cell; 2023 Sep; 83(18):3314-3332.e9. PubMed ID: 37625404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM Structures of the Hsp104 Protein Disaggregase Captured in the ATP Conformation.
    Lee S; Roh SH; Lee J; Sung N; Liu J; Tsai FTF
    Cell Rep; 2019 Jan; 26(1):29-36.e3. PubMed ID: 30605683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104.
    Sweeny EA; Shorter J
    J Mol Biol; 2016 May; 428(9 Pt B):1870-85. PubMed ID: 26608812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering enhanced protein disaggregases for neurodegenerative disease.
    Jackrel ME; Shorter J
    Prion; 2015; 9(2):90-109. PubMed ID: 25738979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolating potentiated Hsp104 variants using yeast proteinopathy models.
    Jackrel ME; Tariq A; Yee K; Weitzman R; Shorter J
    J Vis Exp; 2014 Nov; (93):e52089. PubMed ID: 25407485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiral architecture of the Hsp104 disaggregase reveals the basis for polypeptide translocation.
    Yokom AL; Gates SN; Jackrel ME; Mack KL; Su M; Shorter J; Southworth DR
    Nat Struct Mol Biol; 2016 Sep; 23(9):830-7. PubMed ID: 27478928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.
    Shorter J; Southworth DR
    Cold Spring Harb Perspect Biol; 2019 Aug; 11(8):. PubMed ID: 30745294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity.
    Doyle SM; Shorter J; Zolkiewski M; Hoskins JR; Lindquist S; Wickner S
    Nat Struct Mol Biol; 2007 Feb; 14(2):114-22. PubMed ID: 17259993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.
    March ZM; Mack KL; Shorter J
    Biophys J; 2019 Apr; 116(8):1380-1385. PubMed ID: 30952364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.
    Jackrel ME; Shorter J
    Dis Model Mech; 2014 Oct; 7(10):1175-84. PubMed ID: 25062688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of hsp104, a protein disaggregase.
    Sweeny EA; DeSantis ME; Shorter J
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21989490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing deleterious protein aggregation with re-engineered protein disaggregases.
    Jackrel ME; Shorter J
    Cell Cycle; 2014; 13(9):1379-83. PubMed ID: 24694655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering therapeutic protein disaggregases.
    Shorter J
    Mol Biol Cell; 2016 May; 27(10):1556-60. PubMed ID: 27255695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.